International  +32 (0) 2 732 56 88  +32 (0) 2 732 44 14
France  01 43 25 01 50  01 43 25 01 60
Italy  02 36 00 65 93  02 36 00 65 94
Japan  +81 78 386 0860  +81 78 306 0296
 
 
 
  
Products
1234>>>
Product N° Productname Quantity Price (EUR) Tech sheet  
CC01-08-001 Adenocarcinoma Screen Panel (Stomach/Colon/Rectum) 824
NS21-01-001 Aged grouped female normal skin tissue array 304
CC12-01-002 Bladder carcinoma (multi-tissue combined panel) 304
CC12-01-001 Bladder carcinoma/transitional cell carcinoma, grade I ~ III with normal 304
CS12-01-001 Bladder transitional cell carcinoma 343
CS17-01-001 Brain glioma (Astrocytoma, medulloblastoma, cellular ependymoma, gliomblastoma) with normal brain tissue controls 343
CS17-01-002 Brain glioma (Astrocytoma, medulloblastoma, desmoplastic medulloblastoma, gliomblastoma) with brain normal tissue controls 343
CS17-01-003 Brain glioma (Gliomblastoma, grade IV) with normal brain tissue controls 343
CS17-01-004 Brain glioma (Gliomblastoma, grade IV) with normal brain tissue controls 343
CC08-02-001 Breast carcinoma (combination of margin and normal tissues) [DISCONTINUED, REPLACED BY CC08-02-002] 304
CC08-01-002 Breast carcinoma (Infiltrating duct carcinoma with normal tissue controls) 206
CC08-01-003 Breast carcinoma (Infiltrating duct/atypical medullary/scirrhous carcinoma) 206
CC08-01-005 Breast carcinoma (Infiltrating duct/lobular, papillary, medullary adenocarcinoma, Paget's disease, etc.) 304
CC08-02-002 Breast carcinoma (Mix-matched adjacent and normal tissues) 304
CC08-01-001 Breast carcinoma (multi-tissue combined panel) [DISCONTINUED, REPLACED BY CC08-01-003] 206
CC08-00-001 Breast carcinoma progression array 343
BS08-01-001 Breast fibroma (Fibroadenoma/adenosis/cyst/ectasia/adenosis with fibroadenoma forming, etc.) 304
CS36-01-001 Cartilages sarcoma 343
CC30-01-001 Heart tissue array (Chronic rheumatic valvular/large artery/left atrium/cardiac muscle/atrioventricular node, etc.) 304
CS05-04-001 Colon adenocarcinoma (most grade III) 206
IC00-01-001 Gastritis with intestinal metaplasia and gastric carcinoma tissue arrays 304
IS01-01-001 Gastric ulcer 304
CC05-02-001 Colon adenocarcinoma, self-matched with adjacent and normal tissues 304
CC10-02-001 Cervix carcinoma matched with adjacent and normal 304
CC05-01-012 Colon metastatic carcinoma (metastasis to liver/bladder/lymph nodes) 343
CC05-01-002 Colon carcinoma, grade I ~ III with normal controls 206
CC34-01-001 Head and neck squamous carcinoma 304
CC03-01-001 Hepatocellular carcinoma, grade I ~ III with normal control 206
CS02-04-001 Esophagus squamous cell carcinoma (grade III) 206
CC09-01-001 Endometrial carcinoma (Adenocarcinoma grade I ~ III, few adenosquamous) with normal tissue controls 206
CC02-01-001 Esophagus squamous cell carcinoma (Grade I ~ III) with normal esophagus tissue controls 206
CC03-01-003 Hepatocellular carcinoma, grade I ~ III with normal control 206
CC00-00-002  Endocrine carcinoma/carcinoid tissue array tissue arrays 304
CC02-01-002 Esophagus squamous cell carcinoma (Grade I ~ III) with normal esphoagus tissue controls 206
CS02-02-001 Esophagus squamous cell carcinoma (Grade I) 206
CC02-02-003 Esophagus squamous cell carcinoma self-matched with adjacent and normal tissues 206
CS05-02-001 Colon adenocarcinoma (most Grade I) 206
CS05-01-001 Colon adenocarcinoma (Grade I ~ III) with normal tissue controls 206
CS05-03-001 Colon adenocarcinoma (most grade II) 206
CC02-01-003 Esophagus carcinoma cell carcinoma (Grade I ~ III) with normal esophagus tissue controls 206
CC02-02-001 Esophagus squamous cell carcinoma self-matched with adjacent and normal tissues 304
CS02-03-001 Esophagus squamous cell carcinoma (grade II) 206
NC00-01-009  FDA true 33 normal tissue screen tissue arrays 551
CS02-05-001 Esophagus Adenocarcinoma (Grade I ~ III) 206
CC05-01-001 Colon adenocarcinoma, grade I ~ III with normal control 206
CS03-01-003 Hepatocellular carcinoma, grade I ~ III 206
CC05-02-002 Colon adenocarcinoma, self-matched with adjacent and normal 304
CC02-02-002 Esophagus squamous cell carcinoma self-matched with adjacent and normal tissues 206
CS03-01-001 Hepatocellular carcinoma, grade I ~ III with normal tissue controls 206
CC02-11-001 Esophagus adenocarcinoma (Grade I ~ III) with normal esophagus tissue control 304
 
 
Selected products


Gentaur International   +32 (0) 16 58 90 45
Gentaur Ελλάς Αθήνα   +302111768494  
Gentaur France   01 43 25 01 50
Gentaur Magyarország Budapest  +3619980547
Gentaur Italia   02 36 00 65 93
Gentaur Ireland Dublin  +35316526556
Gentaur Deutschland   +32 (0) 16 58 90 45
Gentaur Luxembourg  +35220880274
Gentaur 日本  +81 78 386 2860
Gentaur Nederland  +31208080893
Gentaur Österreich  +43720880899
Gentaur Norge Oslo  +4721031366
Gentaur Canada Montreal  +15149077481
Gentaur Polska Warszawa  +48223988221
Gentaur Česká republika Praha  +420246019719
Gentaur Sverige Stockholm  +46852503438
Gentaur Danmark  +4569918806
Gentaur Schweiz Zürich  +41435006251
Gentaur Finland Helsset  +358942419041
Gentaur US New York  +17185132983
Europe - Gentaur Molecular Products bvba, Av. de l' Arme 68, B-1040 Brussels Tel:  +32 2 732 56 88 Fax. : +32 2 732 44 14
France 9, rue Lagrange 75005 Paris Tel:  01 43 25 01 50 Fax:  01 43 25 01 60
Italy Tel:  02 36 00 65 93 Fax: 02 36 00 65 94
Japan, Minaatojimaminami-manchi, Chuo-ku, Kobe 065-0047 Tel: +81 78 386 0860Fax: +81 78 306 0296